NCLEX-style practice question
A nurse is caring for a client who takes a medication that must cross the blood-brain barrier to treat Parkinson's disease. Which statement best explains how the combination product achieves this?
- The carbidopa component carries levodopa across the blood-brain barrier, where it is converted to dopamine.
- The carbidopa component blocks dopamine receptors so that levodopa can enter neurons directly.
- The levodopa component is lipid-soluble and crosses the barrier unchanged before being converted to carbidopa.
- The levodopa component dissolves the blood-brain barrier so that carbidopa can enter the brain.
Show answer and rationale
Correct answer: A. The carbidopa component carries levodopa across the blood-brain barrier, where it is converted to dopamine.
Carbidopa is designed to act as a carrier that moves levodopa across the blood-brain barrier, where levodopa is converted to dopamine. The distractor about carbidopa blocking receptors describes a different mechanism and does not address how the drug reaches the brain.
Adapted from Open RN Nursing Pharmacology, Chippewa Valley Technical College, CC BY 4.0.
Category: Pharmacological and Parenteral Therapies / Pharmacological Therapies